Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 166 AL 180

A social dancing pilot intervention for older adults at high risk for Alzheimer's disease and related dementias

Blumen HM, Ayers E, Wang C, Ambrose AF, Verghese J.

Neurodegener Dis Manag. 2020 Aug;10(4):183-194. doi: 10.2217/nmt-2020-0002. Epub 2020 Aug 3.

Mesenchymal Stem Cell Therapy and Alzheimer's Disease: Current Status and Future Perspectives

Kim J, Lee Y, Lee S, Kim K, Song M, Lee J.

J Alzheimers Dis. 2020;77(1):1-14. doi: 10.3233/JAD-200219.

Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs

Lozupone M, Solfrizzi V, D'Urso F, Di Gioia I, Sardone R, Dibello V, Stallone R, Liguori A, Ciritella C, Daniele A, Bellomo A, Seripa D, Panza F.

Expert Opin Emerg Drugs. 2020 Sep;25(3):319-335. doi: 10.1080/14728214.2020.1808621. Epub 2020 Aug 20.

Potential cost savings for selected non-pharmacological treatment strategies for patients with Alzheimer's disease in Finland

Rosenvall A, Sääksvuori L, Finne-Soveri H, Linnosmaa I, Malmivaara A.

J Rehabil Med. 2020 Sep 30;52(9):jrm00106. doi: 10.2340/16501977-2722.

Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval

Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M.

Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.

Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer's Disease Immunotherapy

Castellani G, Schwartz M.

Trends Immunol. 2020 Sep;41(9):794-804. doi: 10.1016/j.it.2020.07.005. Epub 2020 Aug 13.

NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease

Shi JQ, Wang BR, Jiang T, Gao L, Zhang YD, Xu J.

J Alzheimers Dis. 2020;77(3):923-934. doi: 10.3233/JAD-200359.

Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer's Disease Sleep Disorders

Roccaro I, Smirni D.

J Alzheimers Dis. 2020;77(1):113-125. doi: 10.3233/JAD-200478.

Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y.

Int J Mol Sci. 2020 Aug 12;21(16):5783. doi: 10.3390/ijms21165783.

The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy

Tang KS.

Life Sci. 2020 Oct 15;259:118287. doi: 10.1016/j.lfs.2020.118287. Epub 2020 Aug 16.

Harnessing the effects of endurance exercise to optimize cognitive health: Fundamental insights from Dr. Mark P. Mattson

Jachim SK, Sakamoto AE, Zhang X, Pearsall VM, Schafer MJ, LeBrasseur NK.

Ageing Res Rev. 2020 Dec;64:101147. doi: 10.1016/j.arr.2020.101147. Epub 2020 Aug 16.

Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease

Koçyiğit ÜM, Gezegen H, Taslimi P.

Arch Pharm (Weinheim). 2020 Dec;353(12):e2000202. doi: 10.1002/ardp.202000202. Epub 2020 Aug 20.

Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update

Pandey M, Choudhury H, Verma RK, Chawla V, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW.

CNS Neurol Disord Drug Targets. 2020;19(9):648-662. doi: 10.2174/1871527319999200819095620.

Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer's Disease

Uddin MS, Kabir MT, Tewari D, Al Mamun A, Barreto GE, Bungau SG, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

Mol Neurobiol. 2020 Dec;57(12):4961-4977. doi: 10.1007/s12035-020-02065-3. Epub 2020 Aug 20.

Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment

Liu S, Gao J, Zhu M, Liu K, Zhang HL.

Mol Neurobiol. 2020 Dec;57(12):5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias